US Broker Ratings

Kestra Medical Technologies (KMTS) Stock Analysis: A Promising Healthcare Innovator with 59.9% Revenue Growth

Kestra Medical Technologies, Ltd. (KMTS), a United States-based company specializing in medical instruments and supplies, is making waves in the healthcare industry with its innovative approach..

Agios Pharmaceuticals, Inc. (AGIO) Stock Analysis: High Revenue Growth and a Promising Potential Upside

Agios Pharmaceuticals, Inc. (NASDAQ: AGIO), a key player in the biotechnology industry, is turning heads with its impressive revenue growth and substantial potential upside. Specializing in..

Pulse Biosciences, Inc (PLSE) Stock Analysis: A Promising 18.37% Potential Upside Awaits Investors

Pulse Biosciences, Inc. (NASDAQ: PLSE), a trailblazing entity within the healthcare sector, is garnering significant attention from investors due to its innovative strides in bioelectric medicine...

ImmunityBio, Inc. (IBRX) Stock Analysis: 82% Potential Upside Sparks Investor Interest

Investors eyeing the biotechnology sector may want to pay close attention to ImmunityBio, Inc. (NASDAQ: IBRX), a San Diego-based innovator in the field of immunotherapy. With..

CONMED Corporation (CNMD)

⚠️ No article content returned.

..

Phreesia, Inc. (PHR) Stock Analysis: Potential 10.49% Upside with Strong Buy Ratings

Phreesia, Inc. (NYSE: PHR) is emerging as a noteworthy player in the healthcare sector, particularly within the health information services industry. With its market cap standing..

Novavax, Inc. (NVAX) Stock Analysis: A Look at Its 51.3% Potential Upside

Novavax, Inc. (NASDAQ: NVAX) is a prominent player in the biotechnology sector, focusing on the development and commercialization of vaccines. Best known for its COVID-19 vaccine,..

National HealthCare Corporation (NHC) Stock Analysis: Navigating Growth in the Healthcare Sector

National HealthCare Corporation (NYSE: NHC) stands as a notable player in the healthcare sector, particularly within the medical care facilities industry. With a market capitalization of..

Edgewise Therapeutics, Inc. (EWTX) Stock Analysis: Exploring a 34% Potential Upside for Biotech Investors

Edgewise Therapeutics, Inc. (NASDAQ: EWTX), a biopharmaceutical innovator focused on muscle disorder therapies, is capturing investor attention with a compelling potential upside of 34.33%. With a..

Ultragenyx Pharmaceutical Inc. (RARE) Investor Outlook: 63% Potential Upside Amid Promising Biotech Developments

Navigating the complex landscape of biotechnology investments requires a keen eye for both innovation and financial metrics. Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a leading player in..

Teladoc Health, Inc. (TDOC) Stock Analysis: Navigating Challenges with a 19.72% Potential Upside

Teladoc Health, Inc. (NYSE: TDOC) stands as a pivotal player in the rapidly evolving healthcare sector, specifically within the health information services industry. Based in New..

Omnicell, Inc. (OMCL) Stock Analysis: 56.50% Potential Upside Beckons Investors

Omnicell, Inc. (NASDAQ: OMCL), a prominent player in the healthcare technology sector, presents an intriguing opportunity for investors seeking growth within the health information services industry...

GRAIL, Inc. (GRAL)

⚠️ No article content returned.

..

Harrow, Inc. (HROW) Stock Analysis: Healthcare Innovator with a Promising 117.62% Upside

Harrow, Inc. (NASDAQ: HROW) is capturing the attention of investors with its bold strides in the healthcare sector, particularly within the specialty and generic drug manufacturing..

Dyne Therapeutics, Inc. (DYN) Stock Analysis: A Look at 127% Potential Upside in the Biotech Sector

Dyne Therapeutics, Inc. (NASDAQ: DYN), a pioneering force in the biotechnology sector, is catching the eye of investors with a remarkable potential upside of 127.31%. With..

ICU Medical, Inc. (ICUI) Stock Analysis: Exploring a 16.52% Potential Upside in the Healthcare Sector

ICU Medical, Inc. (NASDAQ: ICUI) stands at the forefront of the healthcare sector, specializing in medical instruments and supplies vital for infusion therapy, vascular access, and..

Ligand Pharmaceuticals (LGND) Stock Analysis: A Biotech Gem with 12% Upside Potential

Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) stands out in the biotechnology sector with its impressive portfolio of biopharmaceutical assets and recent robust growth metrics. Headquartered in Jupiter,..

Aveanna Healthcare Holdings Inc (AVAH): Strong Analyst Consensus and Promising Upside Potential

Aveanna Healthcare Holdings Inc (NASDAQ: AVAH), a prominent player in the healthcare sector, stands out in the Medical Care Facilities industry with its diverse range of..

Viridian Therapeutics, Inc. (VRDN)

⚠️ No article content returned.

..

Opko Health, Inc. (OPK) Stock Analysis: Can a 154.6% Upside Justify the Risks?

Opko Health, Inc. (NASDAQ: OPK), a Miami-based healthcare company, is generating buzz among investors with a potential upside of 154.6%, as indicated by its average target..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds